4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-23-017608
Director sold 9,900 shares at $3.46 ($34,252)
- Director acquired 27,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stuglik Brian M Director | 2023-06-13 | Sale 10b5-1 | −9,900 | $3.46 | $34,252 | 31,958 | D |
| Stuglik Brian M Director | 2023-06-13 | Grant or award 10b5-1 | +27,000 | 58,958 | D | ||
| Open-market sales · 9,900 sh · avg $3.46 · $34,252 | |||||||
Loading xslF345X04/rdgdoc.xml…